Intractable Epilepsy study: RNS/DBS activation
Official title Network Effects of Therapeutic Deep Brain Stimulation
ClinicalTrials.gov ID: NCT05600738
What this study is testing
- What it's testing
- The study aims to map short‑term brain responses to electrical stimulation of the thalamus.
- Who it's for
- People who have intractable epilepsy.
- What's involved
- Participants will receive electrical stimulation of the thalamus while their brain activity is monitored.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- diagnosis of Epilepsy
- undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS)
- followed in the outpatient epilepsy clinic
You likely can't join if
- pregnant women
- active psychosis, major depression, or suicidal ideation in the preceding year
- Intelligence quotient (IQ) less than 70 as measured by clinical neuropsychological evaluation
- Do not agree to share their medical records for research purposes
The study team makes the final eligibility decision.
Where it is enrolling
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Houston, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.